CalciMedica News

Graybug Vision | 8-K: Current report

Mar 15, 2023 17:03 ET

Graybug Vision | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer BREUIL ROBERT S

Mar 15, 2023 16:15 ET

Graybug Vision: FY2022 Annual Report

10-K | GRAYBUG VISION, INC. (0001534133) (Filer)

Mar 8, 2023 21:14 ET

Graybug Vision | 4: Statement of changes in beneficial ownership of securities-Officer Zamiri Parisa

Mar 6, 2023 19:04 ET

Graybug Vision | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Guerard Frederic

Mar 6, 2023 19:02 ET

Graybug Vision | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer BREUIL ROBERT S

Mar 6, 2023 18:59 ET

Graybug Vision | DEFA14A: Others

Mar 3, 2023 16:08 ET

Graybug Vision | 8-K: Current report

Mar 3, 2023 16:04 ET

Graybug Vision | DEFA14A: Others

Feb 16, 2023 16:27 ET

Graybug Vision | 8-K: Current report

Feb 16, 2023 16:23 ET

Graybug Vision | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-AffaMed Project Limited(0%),Affamed Therapeutics Limited(0%), etc.

Feb 13, 2023 08:18 ET

Graybug Vision | UPLOAD: Others

Feb 10, 2023 13:30 ET

Graybug Vision | DEFM14A: Definitive proxy statement relating to merger or acquisition

Feb 9, 2023 17:13 ET

Graybug Vision | 8-K: Current report

Feb 9, 2023 16:06 ET

Graybug Vision | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BML Investment Partners, L.P.(5.7%)

Feb 8, 2023 17:06 ET

Graybug Vision | CORRESP: CORRESP

Feb 6, 2023 06:22 ET

Graybug Vision | PRER14A: Preliminary revised proxy soliciting materials

Feb 6, 2023 06:10 ET

Graybug Vision | UPLOAD: Others

Feb 3, 2023 16:30 ET

Graybug Vision | CORRESP: CORRESP

Jan 31, 2023 16:46 ET

Graybug Vision | PRER14A: Preliminary revised proxy soliciting materials

Jan 31, 2023 16:40 ET